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ABSTRACT
Objectives: Patients’ attitudes and expectations of prenatal screening for genetic abnormalities throughout pregnancy are 
rarely analyzed by researchers as emotions and fears are both important and challenging factors. Prenatal counselling has 
never been so difficult as we live in the era of detailed ultrasound scans, cell-free fetal DNA and detailed microarray testing.
The aim of this study was to investigate Polish women’s attitudes towards screening for chromosomal abnormalities and 
fetal defects. 
Material and methods: The study was a prospective survey conducted among a population of Polish women. An electronic 
questionnaire regarding prenatal diagnostics was distributed to a total number of 1072 female volunteers. 
Results: 1044 patients (97.30%) stated that they were motivated to undergo prenatal diagnostics and would want to be 
informed about fetal abnormalities. Over 90% of the respondents would want to be informed about serious defects with 
a high mortality rate (including trisomy 13 or 18). More than half the Polish women (54.83%) stated they were willing to 
consider terminating pregnancy in the case of a severe abnormality. 
Conclusions: Polish women expect prenatal screening. Almost all Polish women would want to be informed about both 
genetic and anatomical abnormalities and over half of them would consider terminating pregnancy in the case of a severe 
abnormality. Willingness to learn about a defect increased with average household income, and the statement of a will to 
terminate pregnancy depended mostly on maternal age and type of fetal abnormality.
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INTRODUCTION
Prenatal diagnostics has an important role in contem-
porary perinatal medicine. Structural defects or genetic 
disorders occur in approximately 3–5% of pregnancies. Such 
a high rate of adverse pregnancy outcomes points to the 
significance of prenatal diagnostics. In Poland the annual 
number of deliveries is approximately 400,000. Considering 
the rate of 3–5% adverse outcomes, each year 12,000 ab-
normalities may occur in infants. However, different ap-
proaches exist to prenatal screening, invasive procedures 
and termination of pregnancy, due to personal and religious 
preferences [1, 2]. Major advances in prenatal medicine 
now offer a variety of diagnostic tools for parents expect-
ing a baby. Medical professionals should always discuss 
all the options with patients. It has to be emphasized and 
properly acknowledged by medical professionals that not all 
patients expect exactly the same counselling and prenatal 
diagnosis. Does a perfect diagnostic algorithm for pregnant 
women exist at all? Do women want to be informed about 
all abnormalities? Which factors influence their attitude? 
Are the best diagnostic strategies for physicians perhaps 
not the most convenient for and acceptable to patients? 
This study aims to answer these questions and describe 
future parents’ expectations towards prenatal diagnostics 
adjusted for their needs.
MATERIAL AND METHODS
The total number of patients who participated in this 
prospective survey was 1,072. An electronic questionnaire 
regarding prenatal diagnostics was distributed to volunteers 
545
Przemyslaw Kosinski et al., Social factors influencing prenatal screening preferences
www. journals.viamedica.pl/ginekologia_polska
via social media and e-mails between November 2016 and 
March 2017. There was no specific algorithm for patient se-
lection, but the only condition necessary for enrolment was 
access to the Internet and female gender. The consent for 
this survey study was obtained from all respondents. Demo-
graphic (age, ethnicity, chronic diseases), social (residence, 
education, religion, economic status) and obstetrical data 
were investigated. Further on in the questionnaire respon-
dents were provided with a basic explanation of fetal ab-
normalities and intellectual disabilities (including trisomies 
13, 18 and 21). Congenital anomalies were described in 
details and marked as five different types with decreasing 
severity and labeled as: type 1 (most die or handicapped 
if survive), type 2 (moderately handicapped, likely to have 
several common health problems), type 3 (health problems 
in only some of the individuals affected), type 4 (autism, in-
tellectual disability) and type 5 (abnormal result of uncertain 
meaning). Description of abnormalities as presented in the 
questionnaire is summarized in Table 1. Questions regarding 
preferences for being informed about specific fetal disorders 
were asked. The local Ethical Committee of Warsaw Medical 
University (Poland) approved this study. 
Statistical analysis 
The data collected were cleaned, tabulated, and subject-
ed to statistical analysis. Apart from the calculation of pro-
portions and contingency tables, a series of χ2 (Chi-Square) 
tests were performed in order to check for relationships 
between survey questions.
RESULTS 
Study group characteristics
In total 1,072 women participated in the questionnaire. 
The majority of them were aged 25–29 years (36.07%) and 
30–34 years (33.46%). The number of relatively younger 
(20–24 years) and older women (35–39 years) was compa-
rable (12.24% and 12.18%, respectively). Almost all (1,062 out 
of 1,072) of the women participating were born in Poland 
(99.07%), as were most of their partners (described as “father 
of the baby”) (96.45%). The vast majority of respondents had 
Table 1. Detailed description of abnormalities presented in the questionnaire
Type of 
abnormality 
detected 
prenatally
Detailed description of abnormality
Type 1
There are anomalies identified in some tests, which are surely known to cause problems for all the babies affected, and such problems 
are so severe that most will not survive; that is, most babies affected with such anomalies, but not all, will die before they are born or 
soon after being born. The few that survive will be very severely handicapped and will need complicated care while they live, for all 
their lives, which will, most often, be short — examples of this type of anomalies are Trisomy 18, an anomaly that causes a disease 
called syndrome of Edwards, and Trisomy 13, an anomaly that causes a disease called syndrome of Patau.
Type 2
There are anomalies identified in some tests, which are surely known to cause problems for all the babies affected, although not as 
severe as Type 1; most of the babies, in which those anomalies were detected, will survive. However, the vast majority of the surviving 
babies will be moderately handicapped and will need someone taking some care of them for all their life, that may be long, although, 
on average, slightly shorter than the population’s average. They are more likely to have several common health problems throughout 
their lives. Some, but not all, of those problems, will be treatable and cured, some partially repaired and some improved. There are 
also interventions that may ameliorate their mental health, although not cure it. One frequently mentioned example of this type of 
defect is Trisomy 21, a defect that causes a disease called Down syndrome.
Type 3
There are anomalies identified in some tests, which are (not as surely as in type 1 or 2, though) known to cause health problems in only 
some of the individuals affected, but not in all. Even in those that will eventually develop health problems caused by the anomalies 
identified by the tests, such health problems are generally considered by many people to be not very severe. For instance, babies, 
in which those anomalies were detected by the tests and that will have health problems, may, when grown-ups, have abnormally 
short or, reversely, tall stature, and are frequently infertile, that is, they cannot have babies on their own; sometimes it will be possible 
to help them having babies, sometimes not. They may have, more frequently than other children, difficulties in school with some 
disciplines, but many times get better with early intervention. Examples of this type of defect are some anomalies of the number of 
the so-called sex chromosomes, the biological determinants of sex.
Type 4
There are anomalies identified in some tests that make individuals carrying them more likely to develop some relatively severe 
neurologic or psychiatric problems. This means that only a proportion of these babies that are found to have the test anomaly, but 
not all, will develop certain mental diseases, such as autism, intellectual disability or schizophrenia, for example. That proportion may 
vary with the test result but the exact value of that proportion may be imprecise and poorly known. Also, not all persons that will 
eventually get affected will have equally severe diseases. Some individuals may have severe symptoms, some may have moderate 
symptoms and some may have mild symptoms. It is important to also understand that only a small proportion of individuals with 
autism, intellectual disability or schizophrenia will have this type of test defects. That is, if the baby test results are normal, that does 
not mean that s/he will not have any of those conditions – autism, intellectual disability or schizophrenia. There are many causes for 
these diseases, only a few of those causes are known, and from those, only a few can be detected by the tests.
Type 5
There are anomalies identified in some tests, for which there are still not enough information to predict, with certainty, that the baby 
will have a health problem. It will only be possible to say that, most likely, but not surely, the baby will have a health problem, although 
it will not be possible to say which problem and its severity.
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had higher education: 79.50% (57.05% of partners), while 
18.92% (39.03% of partners) had had secondary education 
and 1.58% (3.92% of partners) reported an elementary edu-
cation level. More than 58% of the women taking part con-
sidered themselves religious, with over 71% being Christians 
(other religions: 7.55%, no answer 20.55%). Similar results 
concerned partners. A total of 43.04% women were pregnant, 
6.91% within the 6 weeks after delivery and half (50.05%) 
of the respondents were neither pregnant nor in the puer-
perium period. Within the group of pregnant respondents 
most women had been pregnant before (73.07%), as opposed 
to women having their first babies (26.93%). In total, 20.71% 
had had at least one spontaneous miscarriage and 4.38% of 
respondents had had a termination due to medical reasons. In 
6.52% of cases fetal abnormalities of some sort had been 
detected, as opposed to 82.67% who had had no defects 
detected and 10.81% who did not answer this question. 
Patients’ preference 
A total number of 1,044 participants (97.30%) stated 
that they were motivated to undergo prenatal diagnostics 
of some kind as early as in the first trimester of pregnancy 
and in general would want to be informed about fetal ab-
normalities (without specifying exactly which defects — “the 
anomalies possible to detect in routine tests”); 2.7% of re-
spondents would not want to be informed about these ab-
normalities. Within the group of women willing to undergo 
prenatal tests the percentages of women and their partners 
who considered themselves Christians were 96.73% and 
97.24%, respectively. Further on in the questionnaire fetal 
abnormalities were more precisely described. Over 90% of 
respondents would want to be informed about a very seri-
ous defect with a high mortality rate (including trisomy 13 or 
18), as opposed to 2.61% who would want to be informed 
about such an abnormality only after delivery (and not 
during pregnancy). A total of 5.78% of respondents were 
not sure whether they would want to be informed during 
pregnancy or after delivery. The group of women who stated 
their wish to be informed about severe abnormality also 
stated that they would consider termination of pregnancy 
(54.83%), as opposed to 15.71% who would not consider 
termination of pregnancy and 29.47% who were not sure 
what would they do in such circumstances. 92.72% of re-
spondents would want to be informed about less serious de-
fects with a low mortality rate (including life-long defects or 
health problems), as opposed to 3.26% who would want to 
be informed about such an abnormality only after delivery 
(and not during pregnancy). 0.19% of respondents would 
not want to be informed about such issues either before or 
after delivery. In cases of less severe health problems, 41.55% 
of patients would terminate the pregnancy, as opposed to 
22.43% who would not consider pregnancy termination 
at all. As for the third type of abnormality described (only 
a certain number of children with minor health problems 
like infertility in adulthood, short stature or learning diffi-
culties), 87.97% of respondents would want to be informed 
during pregnancy. In such circumstances, 7.21% participants 
would terminate the pregnancy, as opposed to 60.45% who 
would not consider pregnancy termination at all. In cases 
of less severe abnormalities (autism, schizophrenia, higher 
risk of health problems but in some cases no symptoms 
at all) 83.58% of respondents would want to be informed 
about these during pregnancy. In such circumstances, 6.58% 
patients would terminate the pregnancy, as opposed to 
59.26% who would not consider pregnancy termination 
at all. In cases of health issues difficult to detect or con-
firm before birth, 75.02% of respondents would want to be 
informed about these during pregnancy. In such circum-
stances, 4.97% patients would terminate the pregnancy, 
as opposed to 62.86%, who would not consider pregnancy 
termination at all. There is a relationship between income 
and the willingness for prenatal diagnosis of lethal defects 
[χ2 (12) = 33,600, p = 0.0008]. Regardless of the average 
monthly income per household, the majority of respon-
dents stated that they were willing to undergo prenatal 
diagnosis and would want to know about the type 1 defect 
(“the majority of neonates will die”). However, there was 
a tendency for willingness to learn about the defect to in-
crease with average income (75% with an income of < €250, 
87.1% with an income of €250–500, 88.9% with an income of 
€500–1,000 and 94.0% with an income of >  €1,000). These 
data are presented in Table 2. There is a relationship between 
income and the willingness for prenatal diagnosis of milder 
defects (type 3) [χ2 (12) = 24,205, p = 0.019]. Regardless of 
the average monthly income per household, the majority of 
respondents stated they were willing to undergo prenatal 
diagnosis for defect 3. Regardless of parity, motivation to 
recognize defects with a different prognosis was the same 
for all respondents. Over 90% of patients would want to 
be tested for a type 1 defect, about 90% for type 2, around 
80–90% for type 3, around 80% for type 4 and around 70% 
for a type 5 defect. However, the trend is decreasing: the 
better the clinical prognosis for the defect, the fewer the 
patients (regardless of parity) stating their willingness for 
prenatal diagnosis of these conditions.
There is a relationship between the age of the re-
spondents and their statement of willingness to termi-
nate pregnancy in the case of a serious fetal abnormal-
ity [χ2 (19) = 19,558 p = 0.034]. Willingness to terminate 
the pregnancy is most frequently stated by patients aged 
40–44 (60%), 35–39 (53.6%) and 16–19 (42.8%). These data 
are presented in Table 3. 
It is not surprising that in the subgroup of women con-
sidering themselves Christian Catholics the percentage of 
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respondents stating termination of pregnancy as a pos-
sibility is lower than in the entire population studied: the 
overall percentage of respondents declining pregnancy 
termination was 41.5%, but in the Christian Catholic group 
it was 31.5%. 
DISCUSSION
The overall conclusion derived from an analysis of the 
survey is that in general Polish women desire prenatal 
diagnostics (97.30%). It has to be underlined that Poland 
is considered a Catholic country with 88.8% of Poles iden-
tifying themselves as Roman Catholic in 2016 [census con-
ducted by the Central Statistical Office (GUS)] [3]. This is 
also consistent with data gathered in this study — almost 
all respondents and their partners stated that they were 
Roman Catholics (96.73% and 97.24%, respectively). Polish 
women would definitely like to be informed about various 
health problems their baby might have, before the delivery. 
This study has several other interesting findings, many of 
which may differ from common assumptions regarding the 
population of women living in a homogeneous conserva-
tive country. For instance, more than half the respondents 
would consider termination of pregnancy for the most 
severe abnormalities like Patau and Edwards’ syndrome 
(54.83%) but not in cases of minor health problems like 
infertility, short stature or learning difficulties (7.21%). In our 
study the less severe the defect, the lower the determina-
tion to detect the abnormality. This seems reasonable as 
couples who receive a diagnosis of unknown or uncertain 
significance may experience a difficult and stressful preg-
nancy though still have a final chance of having a healthy 
infant [4–6].
As expected, and as confirmed by other studies, ad-
vanced maternal age plays an important role in the decision 
to undergo prenatal diagnostic testing [7, 8]. The statement 
of willingness to terminate pregnancy was stronger with 
advancing maternal age: 53% and 60% within age groups 
35–39 and 40–44, respectively. 
Prenatal counselling has never been so difficult. We 
live in the era of cell-free fetal DNA and detailed microarray 
testing. It is important to understand the benefits and the 
threads that can ensue from each possible screening and 
testing method [9]. But the most important thing is — to 
ensure patients understand their choices and receive accu-
rate information and counselling before making informed 
decisions. This is even more important after realising that 
expectations of prenatal tests may be different for health 
professionals and for patients [10]. The study by Hill et al. 
[11]  revealed that women placed a greater emphasis on test 
safety and having comprehensive information than health 
professionals, who placed more emphasis on accuracy and 
early testing than women. Unfortunately, patients’ attitudes 
towards and expectations of prenatal diagnostics through-
out pregnancy are rarely analysed by researchers as emo-
tions and fears are important, challenging factors to be 
translated into scientific language [12]. 
Table 2. Relationship between stated willingness for prenatal tests concerning lethal defects and average monthly income per household 
[χ2 (12) = 33,600, p = 0.0008]
Stated willingness 
to know if a fetus 
has type 1 defect 
(most children die, 
individual cases 
live until they
reach the age of 1)
Average monthly income per household
< €250 €250–500 €500–1,000 > €1,000
I do not understand the question/ description of this type of defect 0.00% 1.61% 0.47% 0.00%
No, I would not like to know either during pregnancy or after delivery 0.00% 0.00% 0.24% 0.69%
I am not sure whether I would like to know during pregnancy or after 
delivery 16.67% 9.68% 8.98% 2.08%
No, I would not like to know about it during pregnancy, but only after 
delivery 8.33% 1.61% 1.42% 3.24%
Yes, I would like to know during pregnancy 75.00% 87.10% 88.89%  93.98%
Table 3. Relationship between age of respondents and their statement of willingness to terminate pregnancy in the case of type 2 fetal abnormality 
[χ2 (19) = 19,558 p = 0.034]
Age
16–19 20–24 25–29 30–34 35–39 40–44
Would you consider termination of 
pregnancy if your type 2 defect was 
confirmed (the majority of children survive 
the neonatal period, but live with serious 
defects that impair their quality of life)?
No, I would most likely not choose this 
option 28.57% 21.95% 26.84% 22.02% 13.60% 12.00%
I do not know what choice I would make 28.57% 39.02% 37.29% 36.90% 32.80% 28.00%
Yes, I would consider termination in 
such circumstances 42.86% 39.02% 35.88% 41.07% 53.60% 60.00%
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CONCLUSIONS
The results of this study have important implications for health 
professionals and clinical management in Poland. Although the 
social, ethnic or religious background of a couple may alter the 
final decision on types of prenatal tests, almost all women in Po-
land (97%) demand accessibility to prenatal testing. It has to be 
emphasised that there is also a group of women who are seeking 
prenatal testing primarily to obtain information without any inten-
tion to terminate pregnancy due to abnormal results. 
Study limitations
This study has some limitations. The survey was an Inter-
net-based study; it was distributed via e-mail and social me-
dia. Therefore, it has to be acknowledged that only women 
with a basic education, Internet and social media access 
would gain access to the survey. It has to be assumed that 
mostly women with a higher socio-economic status had 
access to the survey. As for all survey studies there is a selec-
tion bias related with the type of the study. It can never be 
accurately foreseen who will agree to participate therefore 
proper randomization in this case is not possible. It has to 
be acknowledged that this selection bias is a major weak-
ness of this study. Although the authors took the greatest 
care to explain all the medical terms in the survey, some 
terms may not have been clear to patients who might have 
answered differently after further clarification. The strengths 
of this study include the large sample of both pregnant and 
non-pregnant women who provided the answers. 
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